`
`PCT
`
`INTERNATIONAL PRELIMJNARY REPORT ON PATENTABILITY
`[Chapter I of the Patent Cooperation Treaty]
`
`(PCT Rule 44bi5)
`
`..-'\pplicant"s or a gent’s File reference
`44854-738601
`
`FOR FURTHER ACTION
`
`See item 4 below
`
`international l'iiing date [(lay/triertth/yearjl
`international application _\o.
`22 February 2018 (22.02.2018)
`PCTIUS2018i'019268
`international Patent Classification (8th etlition unless older edition indicated)
`See relevant information in Form PCTtISAt23?
`
`Priority date {daytf'riiontlflvear")
`22 February 201? {22.02.2017}
`
`Applicant
`TWIST BIOSCIENCE CORPORATION
`
`iliis international preliminary report on patentabiiity [Chapter 1) is issued by the international Bureau on liehail of the
`International Searching Authority under Rule 44 bis.1(a).
`
`This REPORT consists of a total of 8 sheets: including this cover sheet.
`
`In the attached sheets: any reference to the Tt-x-‘ritten opinion of the Tnternational Searching .«'\uthority should he read as a
`rel'erence to the international preliminary report on patentahility (Chapter I) instead.
`
`illis report contains indications relating to the iollowing items:
`
`50‘(
`
`\lo.
`
`I
`
`ISa sis of the report
`
`50‘(
`
`\lo. M
`
`30)L \lo.
`
`3m \lo.
`
`30); \lo.
`
`5m. ‘40.
`
`5m. ‘40.
`
`Priority
`
`Non-establishment oi opinion with regard to novelty, inventive step and industrial
`applicability
`
`T.ack of unity of invention
`
`Reasonetl statement under Article 35(2) with regard to novelty, inventive step or
`industrial applica hi Iity; citations and explanations supporting such statement
`
`Certain documents cited
`
`Certain dciccts in the international application
`
`'
`
`'
`
`'
`
`
`
`
`
`
`
`
`
`50V
`
`.
`
`(iertain observations on the international application
`
`ilie international Bureau will couuuunicate this report to designated Oilices in accordance with i’tules 44bis'.3(c) and 9305.1
`but not, except where the applicant makes an express request under Article 23(2). bei'ore the expiration pl 30 months irom
`the priority date (Rule 44his .2).
`
`
`
`Date of issuance of this report
`27 August 2019 (27.08.2019)
`
`Slmln Baharlou Facsimile No. +41 22 338 82 70
`
`The Tnternational Bureau of WTPO
`34, cheuriu des (joionrbeltes
`i211 Geneva 20. Switzerland
`
`.-'\uthor17.ed officer
`
`e-maii: pct.team9@wipo.inl
`
`i-"orn‘r PC'i'IlBr’LW'J [January 2004]
`
`
`
`PCTIUSZO18/019268 26.06.2018
`
`PATENT COOPERATION TREATY
`
`'
`
`From the
`INTERNATIONAL SEARCHING AUTHORITY
`To; DAVID HARBURGER
`WILSON SONSINI GOODRICH & ROSATI
`550 PAGE MILL ROAD
`PALO ALTO. CA 94304
`
`PCT
`
`WRITTEN OPINION OF THE
`INTERNATIONAL SEARCHING AUTHORITY
`
`(PCT Rule 43ers. I)
`
`2 6w N 2018 .
`FOR FURTHER ACTION
`
`'
`=
`
` attaining.)
`
`
`Applicantis or agent’s file rcfcrcncc
`
`See paragraph 2 below
`
`44854-738601
`
`Priority date (downtown/year)
`International filing date
`
`
`Inteinational application No.
`doybnonihfyear}
`
`
`PCTIUS 18f19268
`22 February 2017 (22.02.2017)
`22 February 2018 (22.02.2018)
`
`
`International Patent Classification (IPC) or both national classification and IPC
`
`“30(3) _ G06F19122. 882‘! 10100, G110 1300 (2018.01)
`
`CFC , G113 2003021 ,G11C 1310009, GGSF 191'10. GOBN 3f126. GOBN 3/123
`
`L________——
`Applicant TWIST BIOSCIENCE CORPORATION
`
`
`
`
`
`
`
`|. This opinion contains indications relating to the following items:
`
`Box No.
`
`|
`
`Basis ofthe opinion
`
`Box No. II
`
`Priority
`
`EDDangina Box No. VIII Certain observations on the international application
`
`Box No. III
`
`Non-establishment of opinion with regard to novelty. inventive step and industrial applicability
`
`Box No. IV
`
`Lack of unity of invention
`
`Box No. V
`
`Reasoned statement under Rule 435:5. 1(a)(i) with regard to novelty, inventive step and industrial applicability;
`citations and explanations supporting such statement
`
`Box No. VI
`
`Certain documents cited
`
`Box No. VII Certain defects in the international application
`
`!
`
`2. FURTHER ACTION
`
`If a demand for intcrnational preliminary examination is made, this opinion will be considered to be a written opinion oftlic
`International Preliminary Examining Authority (“IPEA’”) except that this does not apply where the applicant chooses an Authority
`other than this one to be the IPEA and the chosen [PEA has notified the International Bureau under Rule 56.!bisib) that written
`opinions of this International Searching Authority will not be so considered.
`Ifthis opinion is, as provided above, considered to be a written opinion ofthe IPEA, the applicant is invited to submit to the IFEA
`a written reply together, where appropriate, with amendments, before the expiration of 3 months from the date of mailing of Form
`PCTJISAQ20 or before the expiration of22 months from the priority date, whichever expires later.
`For further options, see I-‘orm PCTJISAQEO.
`
`
`
`Name and mailing address of the ISAIUS Date ofcon'ipletion ofthis opinion
`Authorized officer
` Lee W. Young
`Mail Stop PCT, Alln: ISNUS
`Commissioner for Patents
`
`10 June 2018
`
`PCT Halpdask: 52’1-272-4BUU
`PO. Box 1450, Alexandria. Virginia 22313-1450
`
`PCT 05F: 51-272-1‘774
`
`Facsimile No.
`5?1—2T3-&300
`
`
`Form PCTI’ISAIBT (cover sheet) [January ZOIS)
`
`
`
`PCT/USZO18I019268 26.06.2018
`
`WRITTEN OPINION OF THE
`INTERNATIONAL SEARCHING AUTHORITY
`
`Box No. I
`
`Basis oftltis Opinion
`
`1. With regard to the language, this opinion has been established on the basis of:
`
`
`
`
`
`International application No.
`PCTIUS 1Bi19268
`
`
`
`
`
`
`'3 the international application in the language in which it was filed.
`D a translation oftlte international application into
`furnished for the purposes ofinlernatiorial search (Rules 12.3(a) and 23.1(bJ).
`
`which is the language ot'a translation
`
`This opinion has been established taking into account the rectification ni‘an obvious mistake authorized by or notified to
`this Authority under Rule 9] (Rule 436:3. 1(a)}.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`With regard to any nucleotide auditor amino acid sequence disclosed in the international application, this opinion has I
`been established on the basis ofa sequence listing:
`
`a.
`
`forming part ofthe international application as filed:
`
`El in the form nfan Annex Ci'ST.25 text file.
`D on paper or in the form ofan image file.
`b. E! furnished together with the international application under PCT Rule 13rer.t[a) for the purposes of international
`search onlyr in the Form ofan Annex CEST25 text file.
`
`c. El furnished subsequent to the international filing date for the purposes ofinternational search only:
`D in the form ofan Annex CISTZS text file (Rule l31er.l(a))_
`E! on paper or in the form of an image file {Rule lSter.l(bj and Administrative Instructions, Section '1" I3).
`
`
`
`4. 1:] In addition, in the cast: that more than one version or copy ofa sequence listing has been filed or furnished, the required
`r
`statements that the information in the subsequent or additional copies is identical to that forming part of the application as
`filed or does not go beyond the application as filed, as appropriate, were i‘umished.
`
`5. Additional comments:
`
`
`
`Form PCTIISNB? (Box No. l) (January 2015)
`
`
`
`PCTIUSZO18I019268 26.06.2018
`
`WRITTEN OPINION OF THE
`INTERNATIONAL SEARCHING AUTHORITY
`
`
`International application No.
`PCTJUS 1Bf19268
`
`Box No. IV
`
`Lack ofunity ofinvcntion
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`t.
`
`In response to the invitation (Form PCTI’ISAJZOG) to pay additional fees the applicant has, within the applicable time limit:
`
`El
`
`paid additional Fees.
`
`[3 paid additional fees under protest and. where applicable, the protest fee.
`
`D paid additional fees under protest but the applicable protest fee was not paid.
`
`
`
`8] not paid additional fees.
`
`
`
`2. D This Authority found that the requirement ofunity ofinvention is not complied with and chose not to invite the applicant to
`pay additional fees.
`
`3. This Authority considers that the requirement ofunity ot'invention in accordance with Rule 13.], 13.2 and I13 is
`
`D complied with.
`
`E not complied with for the Following reasons:
`This application contains the following inventions or groups of inventions which are not so linked as to form a single general inventive
`concept under PCT Rule 13.1. In order for all inventions to be examined, the appropriate additional examination fees must be paid.
`
`Group 1+: Claims 1—10. 19-21 drawn to a methodlsystem for storing encrypted information. The methodlsystem for bloencryption will be
`searched to the extent that the bioencryption format encompasses enzymatic based bioencryption. It is believed that claims 1-3. 9. 1t). 19
`.21. 25, 2'." encompass this first named invention. and thus these claims will be searched without fee to the extent that they encompass
`enzymatic based bioenorypt'ron. Additional bioencryption ton-nats will be searched upon the payment of additional! fees. Applicants must
`specify the claims that encompass any additionally elected bioencryption format. Applicants must further indicate. if applicable. the claims
`which encompass the first named invention, if different than what was indicated above for this group. Failure to clearly identify honI any
`paid additional invention lees are to be applied to the "+" groupts) will result in only the first claimed invention to be searched. An
`exemplary election would be a bioancryption format encompassing affinity based bioenoryption (claims 1. 6-10. 19. 24-2?).
`
`Group l|+: Claims 11—18. 28-34. drawn to a metl'lodlsystem tor retrieving encrypted information. Group II+ will be searched upon
`payment of additional fees. The methodlsystem may be searched. for example. to the extent that the encrypted information is retrieved
`using enzymatic based decryption for an additional fee and election as such. It is believed that claims 1 1-13. 28-30 read on this
`exemplary invention. Additional decryption formatts) will be searched upon the payment of additional fees. Applicants must specify the
`claims that encompass any additionally elected decryption format(s]r. Failure to clearly identify how any paid additional invention fees are
`to be applied to the"+" groupts) will result in only the first claimed invention to be searched. Another exemplary election would be a
`decryption format encempasing affinity based decryption {claims 11. 15—13. 23. 33—34].
`
`
`
`The inventions listed as Groups |+ and ||+ do not relate to a single general inventive concept under PCT Rule 13.1 because. under PCT
`Rule 13.2. they lack the same or corresponding special technical features for the following reasons:
`
`Groups ll+ do not require a methodi’system for storing information in a bioencryption format by converting a digital sequence to a plurality
`of oligonucleotide sequences and synthesizing a plurality of oligenucleotide sequences encoding for those. as required by Groups |+.
`
`Groups l+ do not require a methodfsystem for retrieving bloencrypted information by releasing oligonucleotides from a surface. applying
`decryption technique thereto. enriching and sequencing the enriched oligonucleotides. as required by Groups ||+.
`
`The inventions of Groups 1+ each include the special technical feature of bioencrytion formats. recited therein. Each of the inventions of
`Group |+ requires a specific bionencryption format. not required by the other inventions.
`
`The inventions of Groups |I+ each include the special technical feature of dacrytion formats. recited therein. Each of the inventions of
`Group ||+ requires a specific decryption format. not required by the other inventions.
`
`-------------------------------—SEE FIRST SUPPLEMENTAL BOX TO CONTINUE--—-———————---------—---—--—
`
`Special Technical Features
`
`
`
`
`
`
`
`
`
`
`
`
`
`4.
`
`' Consequently, this opinion has been established in respect ofthc following parts ofthe international application:
`
`D all parts.
`
`the pans relating to claims Nos. 1-3. 9. 1D. 19-21I 26, 2? limited to enzymatic based bioencryption
`
`
`Form PCTHSAIZET (Box No. IV) (January 2015)
`
`
`
`PCTIU82018I019268 26.06.2018
`
`WRITTEN OPINION OF THE
`I
`l'
`I
`I
`'
`ll\ ['ERhATIOINAL SEARCHING AU'I HOR'.IT\‘r
`
`International application No.
`PCTfUS 18119258
`
`Box No. V
`
`Reasoned statement under Rule 43br's.l(e)(i] with regard to novelty. inventive step or industrial applicability;
`citations and explanations supporting such statement
`
`Statement
`
`Novelty (N)
`
`Inventive step (IS)
`
`2-3. 9. 10. 20-21. 26. 2?
`1, 19
`
`NONE
`1-3.9.10.19-21.26.27
`
`------------------------------SEE THIRD SUPPLEMENTAL Box To connnUE——--
`
`industrial applicability (IA)
`
`1-3.9.10. 19-21. 25. 27
`NONE
`
`Citations and explanations:
`2.
`Claims 1 and 19 lack novelty under PCT Article 33(2) as being anticipated by US 2005(0053968 A1 to Elharadwaj et al. [hereinafter
`'Bh‘aredwaj').
`
`Regarding claim 1. Bharadwaj discloses a method for storing information. the method comprising:
`a} receiving at least one item of information in a form of at least one digital sequence (abstract “A method for storing information in DNA
`has been developed which includes software and a set of schemes to encrypt. store and decrypt information in terms of DNA bases. The
`main advantages of the present method over exiting art is that it addresses complete set of extended ASCII characters set and thereby.
`encryption of all kind of digital information (text. image. audio etc). First of all. information is. encrypted". thus multiple kinds of digitized
`Information is received for encryption. see Figs. 2 and 4 for overview):
`b) receiving instructions for selection of at least one bioencryption format. wherein the bioencryption format is enzymatic based
`bioencryption [para [001?] "plain textfimage or any digital information is encrypted in terms of DNA sequences using encryption key
`[software]. If the information overflows the limits i.e. it cannot be synthesized in a single place then it is encrypted and fragmented in a
`number of segments [i.e. oligonucleotidesl", para [0019] " the DNA segment(s} istare flanked by known PCR primers
`at both the ends
`i.e. header primers are attached at the beginning of segment and tail primers are attached at the end of the segment". para [0021] "only a
`recipient knowing the sequences of both the primers [starting and tail] would be able to extract the message. using [enzymatic] FCR to
`isolate 5r amplify the encrypted DNA strand];
`:
`c] converting the at least one digital sequence to a plurality of oligonucleotide sequences based on the selected bioencryption format (para
`[001?] "plain texttimage or any digital information is encrypted in terms of DNA sequences
`encrypted and fragmented in a number of
`segments [i.e. oligonucleotides]". see Fig. 1B) ;
`d) synthesizing a plurality of oligonucleotides encoding for the oligonuclaotide sequences (para [0017] " Synthesis of encrypted sequence
`(s) is carried out using DNA synthesizer.". see Figs. 4 and 5); and
`e) storing the plurality of oligonucleotides (para [0020] "DNA is then mixed with the enormous complex denatured DNA strands of genomic
`DNA of human or other organism. As the human genome contains about 3.timee.10.sup.§ nucleotide pairs. fragmented s denatured
`human DNA provides a very complex background for storing the encrypted DNA. The DNA can be stored and transported on paper". see
`Figs. 4 and 5).
`
`Regarding claim 10. Elharadwa] discloses a system for storing infomation (para [001?] "plain textfimage or any digital information is
`encrypted in terms of DNA sequences using encryption key (software).". See Fig. 5 for overview of system}. the system comprising:
`a) a receiving unit (i.e.computer with software program. see Fig. 2) for receiving machine instructions for at least one item of information in
`a form of at least one digital sequence. and machine Instructions for selection of at least one bioencryption format (para [0015]I "The
`method enables the storage of information in DNA. In another embodiment a software based on the above method enables all 256
`Extended ASCII characters to be defined in terms of DNA sequences
`Software named as "DNASTORE" has been developed in Visual
`Basic 6.0 for encryption and decryption of digital information in terms of DNA bases. Using DNASTORE complete extended ASClI
`character set can be encoded 255 different ways". See Figs. 4 and 5}. wherein the bioencryption format is enzymatic [para [0019] "the
`DNA segment(s} isfare flanked by Known PCR primers
`at both the ends i.e. header primers are attached at the beginning of segment
`and tail primers are attached at the end of the segment". para [0021] "only a recipient knowing the sequences of both the primers [starting
`and tail] would be able to extract the message. using [enzymatic] PCR to isolate Sr amplify the encrypted DNA strand}:
`;
`b) a processor unit for automatically converting the at least one digital sequence to a plurality of otigonucleotide sequences based on the
`selected bioencryption format (para [001 'r'] "plain textfimage or any digital information is encrypted in terms of DNA sequences
`encrypted and fragmented in a number of segments [i.e. oligonucleotidesl". see Fig. 4);
`c} a synthesizer unit for receiving machine instructions from the processor unit for synthesizing a plurality of otigonucleotides encoding for
`the oligonucleotide sequences (See Fig, 4 and 5); and
`d) a storage unit for receiving the plurality of oligonucleotides deposited from the synthesizer unit (para [0020] "DNA is then mixed with the
`enormous complex denatured DNA strands of genomic DNA of human or other organism. As the human genome contains about
`3.times.10.sup.9 nucleotide pairs. fragmented & denatured human DNA provides a very complex background for storing the encrypted
`DNA. The DNA can be stored and transported on paper". see Figs. 4 and 5}.
`
`Form Pt‘J‘IB‘ISAt'ZL'tTIr (Box No. V) (January 2015)
`
`
`
`PCTIU82018IO19268 26.06.2018
`
`WRITTEN OPINION OF THE
`INTERNATIONAL SEARCHING AUTl-iOl'tl'l't‘r
`
`International application No.
`PCTJUS 1Bi19268
`
`Supplemental Box
`
`In case the space in any ofthc preceding boxes is not sufficient.
`Continuation or‘:
`Box No. IV (3} Lack of unity of invention:
`
`Common Technical Features
`
`.—------------------------------SEE NE><T SUPPLEMENTAL Box To CONTINUE——————————————
`
`The common technical feature shared by Groups H and |l+ is a method of managing data comprising encryptionidecryption using a
`biological based format. However, this shared technical feature does not represent a contribution over prior art. because the shared
`technical feature is anticipated by the article entitled "NewI Trends of Digital Data Storage in DNA by De Silva et al. (hereinafter "de Silva')
`(Biolv'led Research International (5 September 2016) Vol 2015. Article ID 80?2463. 14 pages).
`
`De Silva teaches a method of managing data comprising using a DNA biological based format (abstract "there emerges a need for a
`storage medium with high capacity. high storage density. and possibility to withstand extreme environmental conditions. DNA emerges as
`the prospective medium for data storage with its striking features. Diverse encoding models for reading and writing data onto DNA. codes
`for encrypting data
`and approaches for developing codons and storage styles have been developed") comprising encrypting and
`decrypting said data (pg. T. col 2. last 2 para — pg 5. col 1. para 2- "Steganography Technique Using DNA Hybridization. This method
`effectively uses the advantages offered by the structure of DNA for vast storing capabilities and parallel molecular computation. This
`approach brings out an algorithm for hiding data in DNA in a digital form One Time Pad (OTP) generated keys are used as encryption
`key. This key is used just only once for exactly one message. The used pad is destroyed by the user after encryption. Figure 2
`summarizes the encryption process using hybridization technique". see Figs. 2-3 for encryptionidecryption. 'After decrypting the message
`receiver destroys the identical pad which is owned by him. Because of this reason this approach is extremely secure. In this algorithm
`single stranded DNA is used as the OTP
`Encrypted message is hidden in a microdot. Strand consisting of the encrypted message is
`placed between two PCR primer sequences ...Without the knowledge about start and and primers one will not be able to read the
`message by amplifying").
`Another common technical feature shared by Groups H and |I+ is a system of managing data comprising a storage unit. a processor unit.
`however this shared technical feature does not represent a contribution over prior art. because the shared technical feature is made
`obvious by De Silva. As discussed above. DNA is the storage unit for DNA. such as a microdot. which is recovered. amplified by
`conventional PCR. and decoded. For said decoding. an artisan of ordinary skill would have readily appreciated that a computer with a
`processor would be used to collect sequence data (invariable generated by a computer controlled seuqencing device. See diagrams in
`Figs 2 and 3). thus De Silva's stored data would comprise a system and processor[s) to encode data by DNA synthesis and decode date
`by amplification and sequencing.
`
`Another common technical feature shared by Groups I+ is claims 1 and 19, however. this feature is anticipated by US 200510053966 A1 to
`Bharadwaj et al. {hereinafter 'Eiheradvvaj'). Bharadwaj teaches (claim 1)a method for storing information. the method comprising:
`a) storing information in a form of at least one digital sequence (abstract "A method for storing information in DNA has been developed
`which includes software and a set of schemes to encrypt. store and decrypt information in terms of DNA bases. The main advantages of
`the present method over exiting art is that it addresses complete set of extended ASCII characters set and thereby. encryption of all kind of
`digital information");
`b} selection of at least one bicencryption format. wherein the bioencryption format is electromagnetic (computer derived} instruction (para
`[0016] "The method enables the storage of information in DNA.
`a software based on the above method enables all 256 Extended ASCII
`characters to be defined in terms of DNA sequences. The basic concept used is to take minimum number of bases to define each
`Extended ASCII character.
`four bases give 4.times.4.times.4.times.4 = 256 distinct sequences. Therefore. with a set of 4 bases.
`complete extended ASCII set has been encoded. Software named as "DNASTORE" has been developed
`for encryption and decryption
`of digital information in terms of DNA bases. Using DNASTORE complete extended ASCII character set can be encoded 255 different
`ways"):
`c) converting the at least one digital sequence to a plurality of oligonucleotide sequences based on the selected bioencryption format.
`d] synthesizing a plurality of oligonucleotides encoding for the oligonucieotide sequences (para [001?] "plain textiimage or any digital
`information is encrypted in terms of DNA sequences using encryption key (software). If the information overflows the limits i.e. it cannot be
`synthesized in a single piece then it is encrypted and fragmented in a number of segments [i.e. oligonucleotides]. Synthesis of encrypted
`sequence is) is carried out using DNA synthesizer.". para [0019] " the DNA segmenlis) isiare flanked by known PCR primers
`at both
`the ends i.e. header primers are attached at the beginning of segment and tail primers are attached at the end of the segment") and e)
`storing the plurality of oligonucleotides (para [0020} "DNA is then mixed with the enormous complex denatured DNA strands of genomic
`DNA of human or other organism. As the human genome contains about 3.times.10.sup,9 nucleotide pairs, fragmented & denatured
`human DNA provides a very complex background for storing the encrypted DNA. The DNA can be stored and transported on paper").
`
`Form PCTIISAJ'ZH (Supplemental Box) (January 2015}
`
`
`
`PCTIU82018I019268 26.06.2018
`
`WRITTEN OPINION OF THE
`INTERNATIONAL SEARCHING AUTHORITY
`
`[ntcmational application No.
`PCTFUS 1309253
`
`Supplemental Box
`
`in cast: the space in tiny oftlie preceding boxes is not sufficient.
`Continuation of:
`.
`Box No. IV [3) Lack of unity of invention:
`
`Bharadwej further teaches (claim 19] system for storing information. the system comprising:
`a) a receiving unit for receiving machine instmcllons for at least one item of information in a form of at least one digital sequence. and
`machine instructions tor selection of at least one bioencryptlon format. wherein the bioencryption format is chemical based bioencryption
`(synthetic DNA sequences) (para [001?] "plain textrirnage or any digital information is encrypted in terms of DNA sequences using
`encryption key lsoftwere).");
`b} a processor unit for automatically converting the at least one digital sequence to a plurality of oligonucleotide sequences based on the
`selected bioencryption format:
`c) a synthesizer unit for receiving machine instructions from the processor unit for synthesizing a plurality of oligonucleotldes encoding for
`the oligonucieotide sequences {para [001?] "plain textfimage or any digital information is encrypted in terms of DNA sequences using
`encryption key (software). If the information overflows the limits i.e. it cannot be synthesized in a single piece then it is encrypted and
`fragmented in a number of segments [i.e. oligonucleotides]. Synthesis of encrypted sequence {5} is carried out using DNA synthesizer.".
`para [0019] " the DNA segmentls) islare flanked by known PCR primers
`at both the ends i.e. header primers are attached at the
`beginning of segment and tail primers are attached at the end of the segment.")-. and
`d] a storage unit for receiving the plurality of oligonucleotides deposited fromthe synthesizer unit (para [0020] "DNA is then mixed with the
`enormous complex denatured DNA strands of genomic DNA of human or other organism. As the human genome contains about
`3.times.10.sup.9 nucleotide pairs, fragmented & denatured human DNA provides a very complex background for storing the encrypted
`DNA. The DNA can be stored and transported on paper").
`
`Another common technical feature shared by Groups l|+ is claims 11 and 28, however, this feature is anticipated by Bharadwai. Bharadwaj
`teaches (claims 1 1 and 28) a method and system for retrieving information comprising
`(a) releasing a plurality of oligonucieotides from a storage unit surtace (DNA stored on paper and mixed with human genomic DNA as
`discussed above). and
`b) applying an enzymatic (PolymerasetPCFt) decryption to the plurality of oligonucleotides with a deposition unit (PCR Machine) (see para
`[0020]). oligonucleotides having primers at each end are stored on paper, para [0017] "digital information is encrypted in terms of DNA
`sequences using encryption key (software)."}
`lc) enriching the plurality of oligonucleotides [para [0021] "only a recipient knowing the sequences of both the primers would be able to
`extract the message, using PCR to isolate 8. amplify the encrypted DNA strand". i.e. enrich the oligonucleotides).
`(d) sequencing enriched oligonucleotides from the plurality of oligonucleotides to generate nucleic acid sequences using a sequencing unit
`enriched oligonucleotides from the plurality of oligonucleotides to generate nucleic acid sequences {para [0021] "Isolated and amplified
`DNA can then be sequenced using automated DNA sequencer.",l and
`(e) a processor unit for automatically converting the nucleic acid sequences to at least one digital sequence. wherein the at least one
`digital sequence encodes for at least one item of information (para [0021] "The DNA sequence obtained can then be convened into digital
`message using encryptionldecryption key (software keyl."}.
`
`As the technical features were known in the art at the time of the invention. they cannot be considered special technical features that would
`otherwise unity the inventions.
`
`Groups l+ and I|+ therefore lack unity under PCT Rule 13 because they do not share the same or corresponding special technical feature.
`
`I
`
`Form PCTflSAr‘ZST (Supplemental Box) (January 2015)
`
`
`
`PCT/USZO18I019268 26.06.2018
`
`WRITTEN OPINION OF THE
`INTERNATIONAL SEARCHING AUTHORITVr
`
`International application No.
`
`PCTJU318t19263
`
`
`
`
`
`
`
`
`
`
`
`
`Supplemental Box
`
`In case the space in any ofthe preceding boxes is not sufficient.
`Continuation of:
`Box \i' No. (2) Citations and Explanations:
`
`Claims 2 and 20 lack an inventive step under F'CT Article 33(3) as being obvious over Bharadwaj
`Bacteria Can Now Store Data" (Dvorsky).
`
`in view of the publication entitled "Living
`
`Regarding claims 2 and 20. Bharadwaj teaches a method and a system for storing information that is encrypted as DNA sequence
`comprising , as discussed for claims 1 and 19. Bharadwaj does not expressly teach that the the enzymatic based bioencryption comprises
`CRISPRrCas based bioencryption. however. Dvorsky teaches storing data in cell DNA using CRISPRJCas based bioencryption (pg 1 para
`1 "Using the CRlSPR gene-editing tool, scientists from Harvard University have developed a technique that permanently records data into
`living cells”. pg 3. para 1 "During the experiment, loose segments of DNA were injected into a strain of E. coli bacteria equipped with
`CRISPWCaH-Casz. But these bits of DNA weren‘t arbitrary- they contained specific strings of data that contained specific sequences of
`letters chosen by the scientists. These segments were introduced one at a time. and the bacteria systematically integrated them in a
`linearly coherent manner to reflect the order in which they were introduced"). Based on Dvcrsky's teaching, it would have been obvious to
`an artisan of ordinary skill to encrypt and store Bharadwal's oligonucleotides using Dvorsky's CRISPRlCas method of integrating strings
`(oligonucleotides) of DNA into a bacterial chromosome for storageihiding, and. for example. recovering said DNA using sequences using
`PCR amplication, because said encryptionistorage method is a valuable alternative means of storing said encrypted DNA.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Claims 3 and 21 lack an inventive step under PCT Article 33(3) as being obvious over Bharadwaj
`ZHENGZHOU LIGHT IND (hereinafter ' ZhengZhou '}
`
`in view ofCN 104?:34848 A to UNIV
`
`Regarding claims 3 and 21. Elharadwai teaches a method and a system for storing information that is encrypted as DNA sequence
`comprising , as discussed for claims 1 and 19. Bharadwaj does not expressly teach that the enzymatic based bioencryption comprises
`instructions for synthesis of the oligonucleotides which are sensitive to an enzyme (restriction enzyme in Table 10). however. ZhengZhou
`teaches encrypting DNA seqments using restriction enzymes (abstract "a recombinant DNA technology based information encrypting and
`hiding method and an application. Firstly, a plain text is coded into a DNA sequence. preprocessing is carried out on the DNA sequence by
`adopting the encryption algorithm. and a pseudo-DNA segment is generated; and then the pseudo-DNA segment and a marker gene
`segment are connected to a DNA plasmid vector by using the restriction enzyme and the ligase. and an obtained recombinant plasmid is
`further hided into a germ body: finally. a cell which contains confidential information is hided into a large number of irrelevant pseudo-cells.
`and the hided cells can be screened out by the selective cultivation. The encrypting and hiding method is applied to the authentication and
`signature technology. Encrypting, hiding and transmitting ot the confidential information are achieved", para [0041] "upon receipt of the
`recipient cell containing the recipient cell masquerading according to the type of selective resistance gene. a cell culture received in an
`appropriate selective medium, having a specific resistance by surviving cells and amplified"; para [0042] "The amplified redolent cells for
`extraction and purification of receptors. restriction endonucleases will disguise the DNA sequence excised from the plasmid vectors and
`their DNA purified and sequenced after extraction. to obtain the DNA sequence disguised base arrangement information"); wherein the
`enzymes are listed in Table 10 (para 0090] The monoclonal colonies were picked. disrupt the cells. centrifuged at high speed. to extract a
`recombinant DNA vector molecule purified amplified dual restriction sites sender design. selection Ndel site and Xhol double digestion
`its sequence obtained by DNA sequencing"). Based on ZhengZhou's teaching. it would have been obvious to an artisan of ordinary skill to
`experiment with ZhengZhou's use of restriction enzyme sites flanking encrypted DNA to selectively release encrypted sections of DNA
`concealed within a cell or a mixture. because said release and sequencing (e .g. with specific primers that ligate to the specific cut ends)
`offer another means of encrypting and storingr'hiding segments of DNA created using the method of Eharadwaj.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Claims 9-10 and 26-2? lack an inventive step under

Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ ChargeStill Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.

This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.

One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site